ホーム › 急性骨髄性白血病 › ニュージャージー › Edison
Edison、NJにおける急性骨髄性白血病の臨床試験
Edisonとその周辺地域（約30マイル以内）の拠点で、急性骨髄性白血病に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
被験者募集中第1相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of CRD3874-SI in People With Leukemia
被験者募集中第1相
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
被験者募集中第3相
- Saint Peter's University Hospital, New Brunswick · 3マイル先
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3マイル先
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
被験者募集中第1/2相
- Saint Peter's University Hospital, New Brunswick · 3マイル先
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3マイル先
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
被験者募集中第3相
- Rutgers Biomedical and Health Sciences, New Brunswick · 3マイル先
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
被験者募集中第2相
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study of Revumenib and Mezigdomide in People With Leukemia
被験者募集中第1/2相
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
被験者募集中第1相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
被験者募集中第1相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
被験者募集中第1相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
被験者募集中第1/2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
被験者募集中第1相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
被験者募集中第1相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
被験者募集中第2相
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
他の都市における急性骨髄性白血病の試験
- Houston, TX85件の研究
- New York City, NY51件の研究
- Boston, MA44件の研究
- Seattle, WA41件の研究
- Baldwin Park, CA40件の研究
- Columbus, OH35件の研究
- Philadelphia, PA34件の研究
- Durham, NC33件の研究
- Atlanta, GA31件の研究
- Tampa, FL29件の研究
- Chicago, IL26件の研究
- Portland, OR25件の研究
Edisonにおける他の研究
- 乳がん68件の研究
- 非小細胞肺癌47件の研究
- がん（全種類）33件の研究
- 前立腺がん29件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 多発性骨髄腫22件の研究
- 膀胱癌21件の研究
- 卵巣がん20件の研究
- 転移性癌20件の研究
- 子宮内膜がん19件の研究
- 尿路上皮（移行上皮）癌18件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。